Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 43386-480

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 43386-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

FDA Label Image

100 Ct (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 02)

100 Ct (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 02)
This is a medication called Orphenadrine Citrate, which is available in the form of extended-release tablets. Each tablet contains 100 mg of Orphenadrine Citrate. The recommended dosage is available in the accompanying prescribing information. It should be stored in a tight, light-resistant container at a temperature between 20°C to 25°C. The medication is manufactured by Novel Laboratories and is distributed by Lupin Pharmaceuticals. The provided code is the NDC number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.